Overview

A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
This study will evaluate the safety and efficacy of long term treatment of SPP100 in patients with essential hypertension. (Trial is not recruiting in the US)
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Novartis
Criteria
Inclusion Criteria:

- Diagnosed as essential hypertension -

Exclusion Criteria:

- Patients with secondary hypertension or suspected of having secondary hypertension.

- Patients suspected of having malignant hypertension

- Patients with any serious diseases or symptoms